Valneva (NASDAQ:VALN) Shares Gap Down – Here’s Why

Valneva SE Sponsored ADR (NASDAQ:VALN) shares gapped down prior to trading on Wednesday . The stock had previously closed at $5.76, but opened at $5.58. Valneva shares last traded at $5.8560, with a volume of 13,252 shares trading hands.

Analyst Ratings Changes

A number of brokerages have commented on VALN. Guggenheim set a $11.00 price objective on Valneva in a research report on Thursday, April 16th. The Goldman Sachs Group lowered Valneva from a “neutral” rating to a “sell” rating and set a $4.90 price objective on the stock. in a research report on Wednesday, April 22nd. Finally, Wall Street Zen upgraded Valneva from a “strong sell” rating to a “sell” rating in a research report on Saturday, May 16th. Three investment analysts have rated the stock with a Buy rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $11.98.

Valneva Price Performance

The company has a debt-to-equity ratio of 2.14, a quick ratio of 1.60 and a current ratio of 2.14. The stock has a market capitalization of $557.00 million, a P/E ratio of -3.14 and a beta of 1.72. The stock has a 50-day simple moving average of $6.68 and a 200 day simple moving average of $8.49.

Valneva (NASDAQ:VALN) last posted its quarterly earnings results on Tuesday, March 31st. The company reported ($0.42) earnings per share (EPS) for the quarter. Valneva had a negative return on equity of 107.63% and a negative net margin of 88.87%.The company had revenue of $35.77 million during the quarter. On average, equities analysts forecast that Valneva SE Sponsored ADR will post -1 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in VALN. China Universal Asset Management Co. Ltd. bought a new stake in shares of Valneva in the fourth quarter valued at about $44,000. Marex Group plc bought a new stake in Valneva during the second quarter worth about $64,000. XTX Topco Ltd bought a new stake in Valneva during the fourth quarter worth about $94,000. VSM Wealth Advisory LLC raised its holdings in Valneva by 125.0% during the third quarter. VSM Wealth Advisory LLC now owns 9,000 shares of the company’s stock worth $110,000 after acquiring an additional 5,000 shares in the last quarter. Finally, JPMorgan Chase & Co. bought a new stake in Valneva during the third quarter worth about $124,000. 11.39% of the stock is currently owned by institutional investors.

About Valneva

Valneva SE is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases. Headquartered in Saint-Herblain, France, the company applies inactivated whole-cell and recombinant technology platforms to address public health needs. Valneva’s research and development efforts span a range of viral and bacterial pathogens, with an emphasis on travel-related and emerging infectious diseases.

Among its marketed products, Valneva offers IXIARO®/JESPECT® for the prevention of Japanese encephalitis and DUKORAL® for the prevention of cholera and diarrhea caused by enterotoxigenic Escherichia coli.